Clinical trial
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With…
NCT00049361 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00049361 |
|---|---|
| Title | Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases |
| Official title | A Phase II Study Of Whole-Brain Radiation Therapy With Thalidomide And Temozolomide In Patients With Newly Diagnosed Brain Metastases |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Radiation |
| Interventions | temozolomide, thalidomide, radiation therapy |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 7, 2004 |
| Completion | Dec 7, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: